Patents held by members of our department

Holger Wille

US provisional patent application US 62/674,916
"An innocuous, structured scaffold for structure-based amyloid disease vaccines and antigens".
Co-inventors: Fang, A., Flores-Fernández, J. M., Wille, H. Filed May22, 2018

United States patent application PCT/CA2019/050691
"Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens",
Co-inventors: Fang, A., Flores-Fernández, JM, Rathog, V., Tang, X. Wille, H. Filed: May 22, 2019.

Ing Swie Goping

Screening of Bad protein expression levels in clinical isolates to determine potential response to taxane therapy. Goping, I.S., Mackey, J.R. and Underhill, D.A. (2014)

Michael Overduin

Solubilisation of membrane proteins" (WO/2011/004158), co-inventors: Tim Dafforn, Tim Knowles and Michael Overduin, University of Birmingham, UK

Joel Weiner

U.S. Patent #6022952; Compositions of Methods for Protein Secretion; February 8, 2000;
Weiner, J.H. & R.J. Turner.

U.S. Patent #6335178; Compositions of Methods for Protein Secretion; January 1, 2002; Weiner, J.H. & R.J. Turner.

European Patent Compositions of Methods for Protein Secretion; Issued January 1, 2009; Weiner, J.H. & R.J. Turner.

US Provisional Patent. YebF, a Novel Protein for Producing Extracellular Recombinant Proteins in Escherichia coli. Filed August 26, 2004. Weiner, J.H & G. Zhang.

European Patent Application No. 05774845.1. YebF, a Novel Protein for Producing Extracellular Recombinant Proteins in Escherichia coli. Filed August 26, 2004. Weiner, J.H & G. Zhang.(Allowed October 27, 2010)

Above patent is also filed in Canada, Australia and Japan.